Hilaris SRL is an ardent academic and scholarly publisher that follows Committee on Publication Ethics guidelines and endorses the World Association of Medical Editors Policy Statement on Geopolitical Intrusion on Editorial Decisions. Hilaris also stick to the International Committee of Medical Journal Editors Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals. Author’s manuscript submission to any of the Hilaris journals is deemed to be considered as having read, understood and have accepted to abide by the publication policy of the Hilaris journal.
Author is an important entity of the entire publishing process as s/he is the individual that makes substantial efforts in the conception, visualization, designing and the materialization of the final outcome as a manuscript for submission/ publication. This involves experiments, clinical trials, data collection through empirical and observation methods for analysis and interpretation. Hilaris firmly believes in honoring the human, animal and environmental rights while conducting studies and collecting data and expects the authors to honor the same. Author is solely responsible for violations if any and Hilaris expects a declaration to this extent that the study did not violate any national or the international laws related to human, animal and the environment
Conflict of Interest
All the submitted manuscripts must include a declaration stating that the study submitted to be considered for publication has no financial and commercial conflict of interest. Editors and the reviewers must also make a statement to this effect that they have executed their functions impartially as reviewers and decision makers without any conflict of personal, financial and commercial interests
Data registration and reporting
Hilaris as publishers support initiatives to improve registration and reporting of data. This includes registering of clinical trials in registries listed on the ICMJE website. If you are unsure whether your trial needs registering, see the ICMJE FAQs. The trial registration number (TRN) and date of registration should be included as the last line of the abstract. Hilaris also encourages authors to register their systematic reviews in a suitable registry (such as PROSPERO). Authors who have registered their systematic review should include the registration number in the manuscript abstract. Authors and reviewers are requested to refer to the following checklists: randomized controlled trials (CONSORT), systematic reviews (PRISMA), observational studies (STROBE), meta-analyses of observational studies (MOOSE), diagnostic accuracy studies (STARD), qualitative studies (RATS), and economic evaluations (CHEERS). Standardized gene nomenclature should be used. Human gene symbols and names can be found in the HUGO Gene Nomenclature Committee (HGNC) database and any enquiries, or requests for new gene symbols, should be directed via email to firstname.lastname@example.org. Authors using unpublished genomic data are expected to abide by the guidelines of the Fort Lauderdale and Toronto agreements. For datasets containing clinical data, authors have an ethical and legal responsibility to respect participants’ rights to privacy and to protect their identity. Authors should gain informed consent for publication of the dataset from participants at the point of recruitment to the trial and state in their cover letter whether informed consent was obtained for publication of patient data. If informed consent was not obtained, authors must state the reason for this, and which body was consulted in the preparation of the dataset. Submission of a manuscript to a Hilaris journal implies that readily reproducible materials described in the manuscript, including all relevant raw data, will be freely available to any scientist wishing to use them for non-commercial purposes, without breaching participant confidentiality. Nucleotide sequences, protein sequences, and atomic coordinates should be deposited in an appropriate database in time for the accession number to be included in the published article. In computational studies where the sequence information is unacceptable for inclusion in databases because of lack of experimental validation, the sequences must be published as an additional file with the article. Any software described in the manuscript should be available for testing by reviewers in a way that preserves their anonymity. The manuscript should include a description in the ‘availability and requirements’ section of how the reviewers can access the software. The software should be available through a website or be included with the manuscript as an additional file. If published, the software application/tool should be readily available to any scientist wishing to use it for non-commercial purposes, without restrictions, such as the need for a material transfer agreement.
Plagiarism and copyright
Any manuscript submitted to a Hilaris journal must be original and must not be under consideration by any other journal. Hilaris Publications checks each article for plagiarism and takes stern actions against cases of publication misconduct. Hilaris endorses ICMJE policies in relation to overlapping publications. Replication of text from the authors’ own previous publications is also not acceptable.
Hilaris Publications ensure that its journals do not publish material that infringes copyright or includes defamatory content. Manuscripts containing material that infringes copyrights and possesses potentially defamatory will be rejected.
Hilaris Publishing takes seriously all allegations of potential misconduct. In cases of suspected research or publication misconduct, it may be necessary for the Editors to contact and share manuscripts with third parties. All research involving humans and animals must have been carried out within the appropriate ethical framework. All digital images in the manuscripts considered for publication will be scrutinized for any indication of manipulation, and manipulation may result in retraction of a published article. Cases of suspected misconduct will be reported to the authors’ institutions.
Corrections and retractions
Corrections to, or retractions of published articles will be made by publishing an Erratum or a Retraction article, without altering the original article in any way other than to add a prominent link to the Erratum/Retraction article. In the exceptional event that material is considered to infringe certain rights or is defamatory we may have to remove that material from our site and archive sites.